A deliberate reduction of low-margin commodity fiber production has boosted net profitability for cellulosic fiber manufacturers despite top-line sales pressure. In H1, FY26, global fiber producer Lenzing Group reported a net profit after tax of €35.6 million - more than double the €15.2 million recorded in H1 2025 - even as consolidated revenues declined by 5.5 per cent to €1.27 billion.
The strategic trade-off reflects an industry-wide prioritization of margin defense over volume growth amid volatile Asian pricing and elevated energy overheads. Operating cash flow rose to €160.4 million, supported by aggressive working capital optimization and inventory drawdown. The brand’s sales initiatives and disciplined cost management are delivering results, confirming the necessity of our strategic realignment, states Mathias Breuer, Chief Financial Officer.
Nonwovens capital shift secures mid-term cash flow
To protect earnings against apparel market volatility, chemical fiber processors are shifting capacity toward non-cyclical hygiene and medical applications. Under its ‘Grow Nonwovens, Reset Textiles’ roadmap, Lenzing is redirecting capital toward specialty offerings including Tencel, Ecovero, and Veocel while exiting standard viscose lines. Backed by an additional €120 million cost-reduction drive through 2027 - following €200 million in efficiency gains during 2025 - the group aims to expand EBITDA by €150 million and achieve long-term operating margins of 20 per cent to 25 per cent.
Wood-based specialty fiber operations
Founded in Austria, Lenzing AG develops bio-based cellulosic fibers for global textile, hygiene, and medical markets. Anchored by flagship brands Tencel and Veocel, the group targets nonwoven expansion and specialty textile applications. Operating on a €4.61 billion balance sheet, mid-term financial guidance targets EBITDA margins between 20% and 25% with net financial leverage below 2.5x.
